Brief: Epirus Biopharmaceuticals announces reprioritization of pipeline

Epirus Biopharmaceuticals

09/05/2016 21:00

May 9 (Reuters) - Epirus Biopharmaceuticals Inc  EPRS.O  
    * Epirus announces reprioritization of pipeline to solely 
focus on biosimilars to treat rare diseases and key leadership 
changes 
    * Epirus biopharmaceuticals inc says  amit munshi steps down 
as president and chief executive officer 
    * Epirus biopharmaceuticals inc says  scott rocklage 
appointed as chief executive officer 
    * Elimination up to approximately 40 percent of positions in 
company's workforce 
    * Epirus biopharmaceuticals inc says  michael wyand named 
president and chief operating officer 
    * Steps include reallocating company's resources to focus on 
development of bow080 
    * Epirus will suspend lead program bow015 and work to 
further evaluate strategic options for program 
 
Source text for Eikon:  ID:nGNXMRJFQa  
Further company coverage:  EPRS.O  
 
 (Bengaluru Newsroom: +1-646-223-8780)